Management of osteosarcoma pulmonary metastases
- PMID: 16458843
- DOI: 10.1053/j.sempedsurg.2005.11.005
Management of osteosarcoma pulmonary metastases
Abstract
Although there has been considerable improvement in survival among children with osteosarcoma over the past 30 years, patients with metastatic disease fare very poorly. The best-case scenario for metastatic patients is a survival rate of 30% assuming complete resection of lung metastases without other disease. To achieve this optimal outcome, an aggressive surgical approach is recommended in which all metastatic disease is resected. This includes metastatic foci that are detected by imaging as well as those only identified by palpation at thoracotomy. Investigation into the biology of the metastatic process of osteosarcoma as well as in identification of molecular features that correlate with prognosis is very active and will likely yield important findings that will impact therapy in the future. An area of investigation that remains needed is the prospective evaluation of the surgical management of these patients with the goal of critically evaluating the impact of the various surgical strategies on patient outcome measures, such as disease-recurrence and survival.
Similar articles
-
Pulmonary resection for metastatic osteosarcomas: a retrospective analysis of 21 patients.Thorac Cardiovasc Surg. 2006 Mar;54(2):120-3. doi: 10.1055/s-2005-872855. Thorac Cardiovasc Surg. 2006. PMID: 16541354
-
Osteosarcoma lung metastases detection and principles of multimodal therapy.Cancer Treat Res. 2009;152:165-84. doi: 10.1007/978-1-4419-0284-9_8. Cancer Treat Res. 2009. PMID: 20213390 Review.
-
[Assessment of prognostic factors in surgical treatment for the pulmonary metastasis of osteosarcoma based on results of 17 patients].Kyobu Geka. 1996 Oct;49(11):896-901. Kyobu Geka. 1996. PMID: 8913060 Japanese.
-
The role of thoracic surgery in the management of metastatic osteogenic sarcoma.Chest Surg Clin N Am. 1994 Feb;4(1):75-83. Chest Surg Clin N Am. 1994. PMID: 8055286
-
Strategies to explore new approaches in the investigation and treatment of osteosarcoma.Cancer Treat Res. 2009;152:517-28. doi: 10.1007/978-1-4419-0284-9_31. Cancer Treat Res. 2009. PMID: 20213413 Review.
Cited by
-
Lung Immune Prognostic Index Could Predict Metastasis in Patients With Osteosarcoma.Front Surg. 2022 Jul 8;9:923427. doi: 10.3389/fsurg.2022.923427. eCollection 2022. Front Surg. 2022. PMID: 35874141 Free PMC article.
-
(3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one inhibited osteosarcoma growth by inducing apoptosis.Exp Ther Med. 2019 Aug;18(2):1107-1114. doi: 10.3892/etm.2019.7681. Epub 2019 Jun 18. Exp Ther Med. 2019. PMID: 31316606 Free PMC article.
-
Commentary: The best outcomes for pulmonary metastasectomy come from picking the right patients.J Thorac Cardiovasc Surg. 2022 Feb;163(2):483-484. doi: 10.1016/j.jtcvs.2020.11.014. Epub 2020 Nov 6. J Thorac Cardiovasc Surg. 2022. PMID: 33309287 Free PMC article. No abstract available.
-
A deep belief network-based clinical decision system for patients with osteosarcoma.Front Immunol. 2022 Nov 18;13:1003347. doi: 10.3389/fimmu.2022.1003347. eCollection 2022. Front Immunol. 2022. PMID: 36466868 Free PMC article.
-
Exosomal communication by metastatic osteosarcoma cells modulates alveolar macrophages to an M2 tumor-promoting phenotype and inhibits tumoricidal functions.Oncoimmunology. 2020 Apr 12;9(1):1747677. doi: 10.1080/2162402X.2020.1747677. eCollection 2020. Oncoimmunology. 2020. PMID: 32313728 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous